The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters

Neurogastroenterology and Motility

Volumn 28, Issue 8, 2016, Pages 1157-1165

  Kimmel, J N ^a   Carlson, D A ^a   Hinchcliff, M ^a   Carns, M A ^a   Aren, K A ^a   Lee, J ^a   Pandolfino, J E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

esophageal motility; high resolution manometry; interstitial lung disease; modified Rodnan skin score; systemic sclerosis

Indexed keywords

CARBON MONOXIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESOPHAGEAL HIGH RESOLUTION MANOMETRY; ESOPHAGEAL MANOMETER; ESOPHAGEAL PRESSURE TOPOGRAPHY; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; FEMALE; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MODIFIED RODNAN SKIN SCORE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSOR; SKIN DISEASE ASSESSMENT; SKIN MANIFESTATION; SYSTEMIC SCLEROSIS;

EID: 84978811127     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12813     Document Type: Article

References (48)

1. Abu-Shakra M, Guillemin F, Lee P. Gastrointestinal manifestations of systemic sclerosis. Semin Arthritis Rheum 1994; 24: 29–39.
2. Sjogren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 1994; 37: 1265–82.
3. Lock G, Holstege A, Lang B, Scholmerich J. Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol 1997; 92: 763–71.
4. Mukhopadhyay AK, Graham DY. Esophageal motor dysfunction in systemic diseases. Arch Intern Med 1976; 136: 583–8.
5. Smout A, Fox M. Weak and absent peristalsis. Neurogastroenterol Motil 2012; 24 (Suppl. 1): 40–7.
6. Ebert EC. Esophageal disease in scleroderma. J Clin Gastroenterol 2006; 40: 769–75.
7. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009; 360: 1989–2003.
8. Gilliam AC. Scleroderma. Curr Dir Autoimmun 2008; 10: 258–79.
9. Treacy WL, Baggenstoss AH, Slocumb CH, Code CF. Scleroderma of the esophagus. A correlation of histologic and physiologic findings. Ann Intern Med 1963; 59: 351–6.
10. Roberts CG, Hummers LK, Ravich WJ, Wigley FM, Hutchins GM. A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma). Gut 2006; 55: 1697–703.
11. Belch JJ, Land D, Park RH, McKillop JH, MacKenzie JF. Decreased oesophageal blood flow in patients with Raynaud's phenomenon. Br J Rheumatol 1988; 27: 426–30.
12. Marie I, Dominique S, Levesque H, Ducrotte P, Denis P, Hellot MF, Courtois H. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 2001; 45: 346–54.
13. Christmann RB, Wells AU, Capelozzi VL, Silver RM. Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence. Semin Arthritis Rheum 2010; 40: 241–9.
14. Bassotti G, Battaglia E, Debernardi V, Germani U, Quiriconi F, Dughera L, Buonafede G, Puiatti P, et al. Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum 1997; 40: 2252–9.
15. Lahcene M, Oumnia N, Matougui N, Boudjella M, Tebaibia A, Touchene B. Esophageal dysmotility in scleroderma: a prospective study of 183 cases. Gastroenterol Clin Biol 2009; 33: 466–9.
16. Roman S, Hot A, Fabien N, Cordier JF, Miossec P, Ninet J, Mion F. Reseau Sclerodermie des Hospices Civils de L. Esophageal dysmotility associated with systemic sclerosis: a high-resolution manometry study. Dis Esophagus 2011; 24: 299–304.
17. Hurwitz AL, Duranceau A, Postlethwait RW. Esophageal dysfunction and Raynaud's phenomenon in patients with scleroderma. Am J Dig Dis 1976; 21: 601–6.
18. Tang DM, Pathikonda M, Harrison M, Fisher RS, Friedenberg FK, Parkman HP. Symptoms and esophageal motility based on phenotypic findings of scleroderma. Dis Esophagus 2013; 26: 197–203.
19. Airo P, Della Casa D, Danieli E, Missale G, Cattaneo R, Cestari R. Oesophageal manometry in early and definite systemic sclerosis. Clin Rheumatol 2005; 24: 370–6.
20. Lock G, Pfeifer M, Straub RH, Zeuner M, Lang B, Scholmerich J, Holstege A. Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis. Am J Gastroenterol 1998; 93: 341–5.
21. Savarino E, Mei F, Parodi A, Ghio M, Furnari M, Gentile A, Berdini M, Di Sario A, et al. Gastrointestinal motility disorder assessment in systemic sclerosis. Rheumatology (Oxford) 2013; 52: 1095–100.
22. Skare TL, Fonseca AE, Luciano AC, Azevedo PM. Autoantibodies in scleroderma and their association with the clinical profile of the disease. A study of 66 patients from southern Brazil. An Bras Dermatol 2011; 86: 1075–81.
23. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581–90.
24. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573–6.
25. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737–47.
26. Hoffmann-Vold AM, Gunnarsson R, Garen T, Midtvedt O, Molberg O. Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease. J Rheumatol 2015; 42: 60–3.
27. Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, Pandolfino JE, International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil 2015; 27: 160–74.
28. Nicodeme F, Pipa-Muniz M, Khanna K, Kahrilas PJ, Pandolfino JE. Quantifying esophagogastric junction contractility with a novel HRM topographic metric, the EGJ-Contractile Integral: normative values and preliminary evaluation in PPI non-responders. Neurogastroenterol Motil 2014; 26: 353–60.
29. Pandolfino JE, Kim H, Ghosh SK, Clarke JO, Zhang Q, Kahrilas PJ. High-resolution manometry of the EGJ: an analysis of crural diaphragm function in GERD. Am J Gastroenterol 2007; 102: 1056–63.
30. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202–5.
31. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281–5.
32. Lahcene M, Oumnia N, Matougui N, Boudjella M, Tebaibia A, Touchene B. Esophageal involvement in scleroderma: clinical, endoscopic, and manometric features. ISRN Rheumatol 2011; 2011: 325826.
33. Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol 2011; 40: 78–83.
34. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000; 43: 2437–44.
35. Vischio J, Saeed F, Karimeddini M, Mubashir A, Feinn R, Caldito G, Striegel K, Rothfield N. Progression of esophageal dysmotility in systemic sclerosis. J Rheumatol 2012; 39: 986–91.
36. Verrecchia F, Laboureau J, Verola O, Roos N, Porcher R, Bruneval P, Ertault M, Tiev K, et al. Skin involvement in scleroderma–where histological and clinical scores meet. Rheumatology (Oxford) 2007; 46: 833–41.
37. Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B, Wigley F, Weisman M, et al. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum 2000; 43: 2445–54.
38. Shand L, Lunt M, Nihtyanova S, Hoseini M, Silman A, Black CM, Denton CP. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model. Arthritis Rheum 2007; 56: 2422–31.
39. Zuber-Jerger I, Muller A, Kullmann F, Gelbmann CM, Endlicher E, Muller-Ladner U, Fleck M. Gastrointestinal manifestation of systemic sclerosis–thickening of the upper gastrointestinal wall detected by endoscopic ultrasound is a valid sign. Rheumatology (Oxford) 2010; 49: 368–72.
40. Xiao Y, Kahrilas PJ, Kwasny MJ, Roman S, Lin Z, Nicodeme F, Lu C, Pandolfino JE. High-resolution manometry correlates of ineffective esophageal motility. Am J Gastroenterol 2012; 107: 1647–54.
41. Lazarescu A, Karamanolis G, Aprile L, De Oliveira RB, Dantas R, Sifrim D. Perception of dysphagia: lack of correlation with objective measurements of esophageal function. Neurogastroenterol Motil 2010; 22: 1292–7, e336–7.
42. Basilisco G, Barbera R, Molgora M, Vanoli M, Bianchi P. Acid clearance and oesophageal sensitivity in patients with progressive systemic sclerosis. Gut 1993; 34: 1487–91.
43. Orringer MB, Dabich L, Zarafonetis CJ, Sloan H. Gastroesophageal reflux in esophageal scleroderma: diagnosis and implications. Ann Thorac Surg 1976; 22: 120–30.
44. Dantas RO, Meneghelli UG, Oliveira RB, Villanova MG. Esophageal dysfunction does not always worsen in systemic sclerosis. J Clin Gastroenterol 1993; 17: 281–5.
45. Medsger TA Jr. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am 2003; 29: 255–73, vi.
46. Hershcovici T, Jha LK, Johnson T, Gerson L, Stave C, Malo J, Knox KS, Quan S, et al. Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2011; 34: 1295–305.
47. Gasper WJ, Sweet MP, Golden JA, Hoopes C, Leard LE, Kleinhenz ME, Hays SR, Patti MG. Lung transplantation in patients with connective tissue disorders and esophageal dysmotility. Dis Esophagus 2008; 21: 650–5.
48. Rubio-Rivas M, Royo C, Simeon CP, Corbella X, Fonollosa V. Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 2014; 44: 208–19.